Abstract 4700: A novel selective EZH2 inhibitor exhibits anti-tumor activity in lymphoma with EZH2 activating mutationsCaretha L. Creasy, Peter J. Tummino, Susan Korenchuk et al.|Cancer Research|2012Cited by 3